Clinical Trial Update: Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and effectiveness of low-dose methotrexate to reduce inflammation in HIV-infected adults on antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Methotrexate (low-dose) (methotrexate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2018-01-10